3Kiyohara C, Washio M, Horiuchi T, et al. Cigarette smoking N-acety ltransferase 2 polymorphisms and systemic lupus erythematosus in a Jap- anese population [ J ]. Lupus, 2009,18 (7) :630-638.
4Boyanov M, Robeva R, Popivanov P. Bone mineral density changes in women with systemic lupus erythematosus [ J ]. Clin Rheumatol,2003,22 (4-5) :318-323.
5Sangle S,D' Cruz DP, Khamashta MA. et al. Antiphospholipid antibod- ies,systemic lupus erythematosus, and non-traumatic metatarsal fractures [J]. Ann Rheum Dis,2004,63(10) :1241-1243.
6Sambrook PN. Steroid-induced osteoporosis [ J ]. Ann Aead Med Singa- pore,2002,31 ( 1 ) :48-53.
7Luigi S, Massimiliano V, Lucia B, et al. Determinants of bone mass in systemic lupus eryth ematosus [ J ] J Rheumatol, 1999,26 ( 6 ) : 1281- 1284.
8Lane NE. An update on glucocorticoid-induced osteoporosis [ J ]. Rheu- matic Diseases Clinics of North America,2001,27( 1 ) :235-253.
9Bischoff-Ferrari HA, Dietrich T, Orar EJ, et al. Positive association be- tween 25-hydroxy vitamin D levels and bone mineral density:a popula- tion-based study of younger and old adults [ J]. Am J Med, 2004,116 (9) :634-639.
10Vander Linden SM,Valkenburg HA, Cats A. Evaluation of diagnsticcriteria for ankylosing spondylitis [J] . Arthritis&Pheum, 1984, 27(4): 361.
